Financhill
Back

Denali Therapeutics Stock Price Chart

  • The current trend is relatively stagnant and DNLI is experiencing slight buying pressure.

Denali Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 20.62 Buy
20-day SMA: 20.78 Buy
50-day SMA: 23.74 Sell
200-day SMA: 23.07 Sell
8-day EMA: 20.91 Buy
20-day EMA: 21.25 Buy
50-day EMA: 22.91 Sell
200-day EMA: 23.57 Sell

Denali Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 51.28 Buy
Chaikin Money Flow: 135724 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.99 - 22.59) Buy
Bollinger Bands (100): (22.36 - 28.76) Sell

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Denali Therapeutics Stock

Is Denali Therapeutics Stock a Buy?

DNLI Technical Analysis vs Fundamental Analysis

Sell
41
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics a Buy or a Sell?

Denali Therapeutics Stock Info

Market Cap:
3.2B
Price in USD:
21.93
Share Volume:
863.2K

Denali Therapeutics 52-Week Range

52-Week High:
33.33
52-Week Low:
14.56
Sell
41
Denali Therapeutics (DNLI) is a Sell

Denali Therapeutics Share Price Forecast

Is Denali Therapeutics Stock a Buy?

  • Denali Therapeutics share price is 21.93 while DNLI 8-day exponential moving average is 20.91, which is a Buy signal.
  • The stock price of DNLI is 21.93 while Denali Therapeutics 20-day EMA is 21.25, which makes it a Buy.
  • Denali Therapeutics 50-day exponential moving average is 22.91 while DNLI share price is 21.93, making it a Sell technically.
  • DNLI stock price is 21.93 and Denali Therapeutics 200-day simple moving average is 23.57, creating a Sell signal.

Fundamental Analysis of Denali Therapeutics

Is Denali Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.79 per share.

Technical Analysis of Denali Therapeutics

Should I short Denali Therapeutics stock?

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.